Innate Pharma to Hold Q1 2024 Business Update Call

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a clinical-stage biotechnology company, has announced an upcoming conference call to discuss the progress of its business during the first quarter of 2024. The call is scheduled for Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT.

Key figures who will be participating in the call include:
- Hervé Brailly, Chief Executive Officer
- Sonia Quaratino, Executive Vice President, Chief Medical Officer
- Yannis Morel, Executive Vice President, Chief Operating Officer
- Frédéric Lombard, Senior Vice President, Chief Financial Officer
- Arvind Sood, Executive Vice President, President of US Operations

The call will be accessible via a live webcast, with the link provided in the company's investor section on their website. Additionally, participants have the option to join through a telephone registration link. A recording of the webcast will be available on Innate Pharma's website for 90 days post-event.

Innate Pharma, headquartered in Marseille, France, with a US office in Rockville, MD, specializes in developing immunotherapies for cancer treatment. The company leverages its proprietary ANKET® (Antibody-based NK cell Engager Therapeutics) platform to harness the innate immune system using therapeutic antibodies.

Innate Pharma's portfolio features several advanced programs, including lacutamab for treating cutaneous T cell lymphomas and peripheral T cell lymphomas, and monalizumab, developed in collaboration with AstraZeneca, for non-small cell lung cancer. Additionally, the company is advancing its ANKET® multi-specific NK cell engagers aimed at targeting various tumor types.

The company is recognized as a trusted partner by prominent biopharmaceutical companies like Sanofi and AstraZeneca, as well as leading research institutions. These partnerships are pivotal in accelerating innovation and research for the benefit of patients.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!